451 Results

People

  1. O'Reilly
    O'Reilly
  2. Abou-Alfa
    Abou-Alfa
  3. Aghajanian
    Aghajanian
  4. Motzer
    Motzer
  5. DeMatteo
    DeMatteo
  6. Brennan
    Brennan
  7. Jarnagin
    Jarnagin
  8. Kelsen
    Kelsen
  9. Maki
    Maki
  10. Schwartz
    Schwartz

Groups

  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (216)
  3. Hematologic Malignancies, Division of (83)
  4. Gastrointestinal Oncology Service (75)
  5. Surgery (72)
  6. Center for Pancreatic Cancer Research (70)
  7. Center for Hematologic Malignancies (60)
  8. Epidemiology and Biostatistics (55)
  9. Survivorship Research (51)
  10. Gynecology Disease Management Team (48)
  1. "abdominal pain"
Formats
  1. Journal Article (429)
  2. Review (12)
  3. Conference Paper (2)
  4. Correspondence (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (216)
  3. Hematologic Malignancies, Division of (83)
  4. Gastrointestinal Oncology Service (75)
  5. Surgery (72)
  6. Center for Pancreatic Cancer Research (70)

More Groups

People
  1. Eileen O'Reilly (28)
  2. Carol Aghajanian (22)
  3. Ghassan Abou-Alfa (22)
  4. Robert Motzer (18)
  5. Ronald DeMatteo (16)
  6. Robert Maki (13)

More People

Years
  1. 2025 (15)
  2. 2024 (42)
  3. 2023 (28)
  4. 2022 (24)
  5. 2021 (12)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Clinical Cancer Research (29)
  3. Gynecologic Oncology (22)
  4. Lancet Oncology (22)
  5. Cancer (17)
  6. Blood (12)

More Publications

Publishers
  1. Elsevier Inc. (63)
  2. Elsevier Science, Inc. (43)
  3. Springer (39)
  4. American Society of Clinical Oncology (38)
  5. American Association for Cancer Research (29)
  6. Lippincott Williams & Wilkins (27)

More Publishers

Results (451)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects
    Journal Article

    Gonzalez, R. S.; Horton, R. K.; Zhang, X.; Graham, R. P.; Longacre, T. A.; Mehrotra, A.; Allende, D. S.; McHugh, K. E.; Shia, J.; Westerhoff, M.; more...
    Histopathology (2025)

    Fulltext@MSK | Save
  • Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: A first-in-human, single-centre, phase 1 trial
    Journal Article

    Lou, E.; Choudhry, M. S.; Starr, T. K.; Folsom, T. D.; Bell, J.; Rathmann, B.; DeFeo, A. P.; Kim, J.; Slipek, N.; Jin, Z.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
    Journal Article

    Gouda, M. A.; Voss, M. H.; Tawbi, H.; Gordon, M.; Tykodi, S. S.; Lam, E. T.; Vaishampayan, U.; Tannir, N. M.; Chaves, J.; Nikolinakos, P.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: A randomized phase 3 trial
    Journal Article

    Kopetz, S.; Yoshino, T.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; Yaeger, R.; Maughan, T. S.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Management approaches for primary hepatic lymphoma: 10 year institutional experience with comprehensive literature review
    Journal Article

    Ma, J.; Daou, R.; Bou Eid, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Case report: Clinical and molecular features of renal gastrointestinal tumor
    Journal Article

    Makker, S.; Rammal, R.; Gu, P.; Dalbagni, G.; Al-Ahmadie, H.; Agaram, N. P.; Iyer, G.; Kotecha, R. R.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
    Journal Article

    Scott, S. C.; Farago, A.; Lai, W. V.; Zahurak, M.; Rudek, M. A.; Murray, J.; Carducci, M. A.; Uziel, T.; Takebe, N.; Gore, S. D.; more...
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • SWOG S1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers
    Journal Article

    Shroff, R. T.; King, G.; Colby, S.; Scott, A. J.; Borad, M. J.; Goff, L.; Matin, K.; Mahipal, A.; Kalyan, A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A woman with mycosis fungoides, vitiligo, and a new hand nodule
    Journal Article

    Feghali, J.; Lavin, L.; Ng, S.; Linos, K.; Geller, S.
    International Journal of Dermatology (2025)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
    Journal Article

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
    Blood (2025)

    Fulltext@MSK | Save